Definitive concurrent chemoradiotherapy with paclitaxel plus carboplatin is superior to cisplatin plus 5‐fluorouracil in patients with inoperable esophageal squamous cell carcinoma using retrospective, real‐world evidence-Reference-Cited by-同舟云学术

Definitive concurrent chemoradiotherapy with paclitaxel plus carboplatin is superior to cisplatin plus 5‐fluorouracil in patients with inoperable esophageal squamous cell carcinoma using retrospective, real‐world evidence

Published:2021-10-27 Issue:23 Volume:10 Page:8300-8309
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Hsieh Jason Chia‐Hsun¹²³^ORCID,Chiang Pin‐Chun¹³,Hung Tsung‐Min³⁴,Chao Yin‐Kai³⁵,Kuo Yung‐Chia¹²³,Wen Chih‐Tsung³⁵⁶,Su Po‐Jung²³,Peng Meng‐Ting²³,Chen Huan‐Wu³⁷⁸,Liu Hui‐Ling⁹,Chang Hsien‐Kun¹²³,Wu Min‐Hsien¹²³,Wang Hung‐Ming¹²³

Affiliation:

1. Division of Hematology‐Oncology Department of Internal Medicine New Taipei Municipal TuCheng Hospital New Taipei City Taiwan

2. Division of Hematology‐Oncology Department of Internal Medicine Chang Gung Memorial Hospital at Linkou Taoyuan City Taiwan

3. College of Medicine Chang Gung University Taoyuan Taiwan

4. Department of Radiation Oncology Chang Gung Memorial Hospital at Linkou Taoyuan City Taiwan

5. Division of Thoracic Surgery Department of Surgery Chang Gung Memorial Hospital at Linkou Taoyuan City Taiwan

6. Division of Thoracic Surgery Department of Surgery New Taipei Municipal TuCheng Hospital New Taipei City Taiwan

7. Department of Emergency and Critical Care Radiology Chang Gung Memorial Hospital at Linkou Taoyuan City Taiwan

8. Department of Emergency and Critical Care Radiology New Taipei Municipal TuCheng Hospital New Taipei City Taiwan

9. Case Manager Department of Nursing Cancer CenterChang Gung Memorial Hospital at Linkou Taoyuan Taiwan

Funder

Chang Gung Memorial Hospital, Linkou

Chang Gung Medical Foundation

Ministry of Science and Technology, Taiwan

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4025

Reference31 articles.

1. Cancer statistics, 2019

2. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

3. Annual Report 2017 Health promotion administration ministry of health and welfare of Taiwan cancer registry

4. Esophageal Carcinoma

5. National Comprehensive Cancer Network. Esophageal and Esophagogastric Junction Cancers (Version 2.2020)https://www.nccn.org/professionals/physician_gls/pdf/esophageal.pdfAccessed on June 26th 2020.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of Response to Chemoradiotherapy by Dynamic Changes of Circulating Exosome Levels in Patients with Esophageal Squamous Cell Carcinoma;International Journal of Nanomedicine;2024-02

2. Neoadjuvant camrelizumab plus chemotherapy in locally advanced oesophageal squamous cell carcinoma: a retrospective cohort study;BMC Surgery;2023-05-09

3. Comparison of Efficacy and Safety of First-Line Chemoimmunotherapy in Advanced Esophageal Squamous Cell Carcinoma: A Systematic Review and Network Meta-Analysis;Journal of Clinical Pharmacy and Therapeutics;2023-02-06

4. Retrospective study of the combination of TP and PF regimens with or without immune checkpoint inhibitors for the first-line treatment of locally advanced or advanced esophageal squamous cell carcinoma;Therapeutic Advances in Medical Oncology;2023-01

5. Comparison of Efficacy and Safety of Taxanes Plus Platinum and Fluorouracil Plus Platinum in the First-Line Treatment of Esophageal Cancer: A Systematic Review and Meta-Analysis;Current Oncology;2022-09-16